Skip to main content
Clinical Trials/NCT02120599
NCT02120599CompletedNot Applicable

Randomized Controlled Trial of the Impact of Treating Moderately Malnourished Women in Pregnancy

Washington University School of Medicine2 sites in 1 country1,867 target enrollmentStarted: March 1, 2014Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
1,867
Locations
2
Primary Endpoint
Maternal change in mid-upper arm circumference (MUAC)

Study Overview

Brief Summary

Malnutrition during pregnancy is more common in poor women in the developing world due to inadequate dietary intake combined with increased nutrient requirements; pregnancy risk is more consequential than among other demographic groups with increased risk of maternal and infant mortality and the lifelong effects of fetal malnutrition. The benefits of treating moderate malnutrition during pregnancy remain largely undocumented. This study tests the hypothesis that providing either a fortified flour or fortified paste-based supplementary food designed to replete the nutrient deficits during pregnancy will result in improved maternal nutritional recovery rates and higher infant birth weights and lengths. This study is a randomized, controlled clinical trial of 3 supplementary foods in 1800 moderately malnourished Malawian women who are pregnant. Subjects will receive one of 3 food rations: 1) a ready-to-use supplementary food formulated to deliver about 200% of the recommended daily allowance (RDA) of most micronutrients in pregnancy (RUSF-P), 2) corn soy blend with a multiple micronutrient tablet chosen to deliver about 200% of the RDA of most micronutrients (CSB-P) or 3), the standard of care which is a corn soy blend with supplementary iron and folic acid (CSB), delivering between 0-350% of the RDA. Subjects will receive the supplementary food until they recover from MAM. The outcome of the pregnancy and maternal nutritional status will be followed until 3 months after delivery.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Single (Outcomes Assessor)

Eligibility Criteria

Ages
14 Years to — (Child, Adult, Older Adult)
Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Pregnant and consenting to study participation and HIV testing (if not already performed)
  • •mid-upper-arm circumference (MUAC) ≤ 23 cm
  • •planning to stay in the area and attend the clinic during pregnancy and for 3 months post partum

Exclusion Criteria

  • •Pregnancy complications such as gestational diabetes, pre-eclampsia, hypertension
  • •Severe anemia (Hg <7.0 mg/dl)
  • •Severe malnutrition
  • •under 18 years of age
  • •over estimated 35 weeks of gestation

Arms & Interventions

corn-soy-blend

Active Comparator

This is the control group for the study, which will receive the Malawi standard of care. The treatment provided to women randomized to this arm of the study includes daily iron (60 mg) and folic acid (400 mcg) supplementation, along with 4 kg/2 weeks corn-soy blend (~357 gm/d CSB).

Intervention: corn-soy blend (Dietary Supplement)

corn-soy-blend + multiple micronutrients

Experimental

The treatment provided to women randomized to this arm of the study includes 200gm/d CSB along with a standard maternal multiple micronutrient tablet, which together provide a comparable amount of energy, protein and micronutrients to the ready-to-use supplemental food. The micronutrient supplement known as the United Nations Children's Emergency Fund (UNICEF) / World Health Organization (WHO) / United Nations University (UNU) international multiple micronutrient preparation (UNIMMAP) is widely available and has been used in many settings worldwide in pregnant women.

Intervention: corn-soy blend (Dietary Supplement)

corn-soy-blend + multiple micronutrients

Experimental

The treatment provided to women randomized to this arm of the study includes 200gm/d CSB along with a standard maternal multiple micronutrient tablet, which together provide a comparable amount of energy, protein and micronutrients to the ready-to-use supplemental food. The micronutrient supplement known as the United Nations Children's Emergency Fund (UNICEF) / World Health Organization (WHO) / United Nations University (UNU) international multiple micronutrient preparation (UNIMMAP) is widely available and has been used in many settings worldwide in pregnant women.

Intervention: UNIMMAP (Dietary Supplement)

ready-to-use supplementary food

Experimental

RUSF-P (ready-to-use supplementary food) provides 750 kcal/d, 20 g protein/d, and 200% of RDA/d for most micronutrients during pregnancy (except for vitamins A, B3, folic acid, minerals iodine, magnesium, and calcium which will remain near 100%)

Intervention: ready-to-use supplementary food (Dietary Supplement)

corn-soy-blend

Active Comparator

This is the control group for the study, which will receive the Malawi standard of care. The treatment provided to women randomized to this arm of the study includes daily iron (60 mg) and folic acid (400 mcg) supplementation, along with 4 kg/2 weeks corn-soy blend (~357 gm/d CSB).

Intervention: folic acid (Dietary Supplement)

corn-soy-blend

Active Comparator

This is the control group for the study, which will receive the Malawi standard of care. The treatment provided to women randomized to this arm of the study includes daily iron (60 mg) and folic acid (400 mcg) supplementation, along with 4 kg/2 weeks corn-soy blend (~357 gm/d CSB).

Intervention: iron (Dietary Supplement)

Outcomes

Primary Outcomes

Maternal change in mid-upper arm circumference (MUAC)

Time Frame: up to 40 weeks

average change in mid-upper-arm circumference

infant birth weight

Time Frame: up to 40 weeks

mean birth weights of infants born to mothers in the study

Proportion recovered from moderate acute malnutrition (MAM)

Time Frame: up to 40 weeks

proportion of women who reach mid-upper arm circumference (MUAC) \> 23.5 cm for 2 consecutive visits

premature delivery

Time Frame: up to 36 weeks

proportion of infants born prematurely

infant birth length

Time Frame: up to 40 weeks

mean birth length of infants born to women in the study

Secondary Outcomes

  • pregnancy complications(up to 40 weeks)
  • maternal weight gain(up to 40 weeks)
  • infant length at 3 months(3 months)
  • maternal hemoglobin(8 weeks)
  • infant survival at 3 months(3 months)
  • infant weight at 3 months(3 months)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (2)

Loading locations...

Similar Trials